Rare diseases
Investigational molecules
Locations
Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy
BelgiumA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
BelgiumStudy of Different Dosing Schedules of Osimertinib in Patients with EGFR Mutated Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
BelgiumStudy of BNT326 alone and with BNT327 in patients with advanced solid tumors: Testing safety and effectiveness of new cancer treatments
BelgiumStudy of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)
BelgiumStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
BelgiumStudy of Ropivacaine for Pain Control in Patients Having Open Heart Surgery Through Chest Bone Incision
BelgiumStudy of HPV antibody response in urine samples before and after HPV 9-valent vaccine in people with Human Papillomavirus infection
BelgiumStudy of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants
BelgiumStudy of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment
BelgiumStudy of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
